The Dow and S&P broke their three day losing streak and all three indexes posted gains for the week. Today’s impetus was Pfizer’s announcement that their vaccine might be ready for U.S. authorization as soon as the end of November which gave the market a much wanted timeline and sent Pfizer’s stock up almost 4 percent. Other good news included retail sales zooming past forecasts and the unexpected surprise of consumer confidence not just holding steady but actually going up despite some dire potential outcomes. Q3 is just getting underway with 49 companies reporting and 86% of these beating forecasts, though admittedly the forecasts have all set a low bar. Volume was again below average at 8.8 billion.
FRI OCTOBER 16, 2020 4:30 PM
Dow advances, S&P ekes out gain
as vaccine timeline comes into focus
DJ: 28,494.20 -19.80 NAS: 11,713.87 -54.86 S&P: 3,483.34 -5.33 10/15
DJ: 28,606.31 +112.11 NAS: 11,671.56 -42.32 S&P: 3,483.81
+0.47 10/16
NEW
YORK (Reuters) - The S&P 500 posted a nominal gain on Friday as further
clarity regarding the timeline for the development of a coronavirus vaccine and
much better-than-expected retail sales data brought buyers back to the market. The Dow also joined the S&P in positive
territory, both indexes snapping a three-day losing streak driven by halted
vaccine trials and continued wrangling in Washington over a new pandemic relief
package. But the Nasdaq ended the session lower. Even so, they all posted gains on the week.
Pfizer Inc announced it could apply for U.S. authorization for the
COVID-19 vaccine it
is developing with German partner BioNTech in November. Pfizer’s stock gained 3.8%. “The two highest-level market movers are the vaccine
timeline and stimulus optimism,” said Ross Mayfield, investment
strategist at Baird in Louisville, Kentucky. “Sometimes the market gets a
reality check that even if we get a vaccine early next year that’s an
incredibly aggressive and optimistic timeline.”
Retail
sales in September blew past analyst expectations and consumer sentiment for
the current month surprised to the upside, according to two separate economic reports. But with previous
stimulus having run its course, the outlook is uncertain unless Washington can
reach an agreement on a fresh round of fiscal aid. “It’s
important from the retail sales data to see that the consumer is not just
limping a long but exceeding expectations,” Mayfield added. “I don’t know how
long this can continue without stimulus but it’s heartening to see the consumer has held up pretty well despite
some dire expectations.”
On the stimulus front, U.S. Treasury
Secretary Steven Mnuchin told House Speaker Nancy Pelosi that President Donald
Trump would “weigh in” with Senate Majority Leader Mitch McConnell if an
agreement is reached on a new pandemic relief package. House Republican leader
Kevin McCarthy, however, said he does not expect an agreement to be reached
ahead of the Nov. 3 election as long as Pelosi is involved.
The
Dow Jones Industrial Average rose 112.11 points, or 0.39%, to 28,606.31, the
S&P 500 gained 0.47 points, or 0.01%, to 3,483.81 and the Nasdaq Composite
dropped 42.32 points, or 0.36%, to 11,671.56.
Of the 11 major sectors in the S&P 500, seven ended the session in
the black. While utilities had the largest percentage gain, energy suffered the
biggest loss.
Third-quarter
reporting season burst from
the starting gate this week, with 49 of the companies in the S&P 500 having reported. Of those, 86% have cleared the low bar
set by expectations, according to Refinitiv.
Oil services company Schlumberger NV
posted its third straight quarterly loss due to falling crude prices and
plunging demand. Its shares dropped 8.8%.
Railroad operator Kansas City Southern shed 2.7% and transportation and
logistics company J.B. Hunt Transport Services Inc tumbled 9.7% after the
companies’ quarterly results were hit dropping shipping demand. The Dow Jones Transport index, considered a
barometer of economic health, fell 1.3%.
Shares of fitness company Peloton Interactive Inc lost 3.7% after
announcing a recall of faulty pedals on its popular exercise bikes.
Declining issues outnumbered advancing
ones on the NYSE by a 1.30-to-1 ratio; on Nasdaq, a 1.07-to-1 ratio favored
decliners. The S&P 500 posted 50 new
52-week highs and no new lows; the Nasdaq Composite recorded 98 new highs and
20 new lows.
Volume
on U.S. exchanges was 8.82 billion shares, compared with the 9.31 billion average over the last 20
trading days.
No comments:
Post a Comment